10.1088/0034-4885/73/9/094601 Reports Prog
2.5 Statistical analysis We pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) using the DerSimonian and Laird random-effects model, which accounts for between study heterogeneity
Kilany A, Raouf ERA, Gaber AA et al (2012) Elevated serum Bcl-2 in children with temporal lobe epilepsy
102 The investigation of semaglutide at 0.1, 0.2 and 0.4 mg/day for NASH resolution without fibrosis worsening after 72 weeks of therapy has recently been completed, and the results are expected (NCT02970942)
Why titration stretches the timeline Semaglutide protocols are typically introduced gradually rather than at a full level from day one
Many of our patients choose to inject once every 6 weeks however, further lowering the cost (usually the patient will feel when the effects are starting to wear off and choose that point to receive a further injection)